Log in to save to my catalogue

High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovar...

High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovar...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9659939

High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients

About this item

Full title

High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients

Publisher

London, England: SAGE Publications

Journal title

Journal of international medical research, 2022-11, Vol.50 (11), p.3000605221135864-3000605221135864

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Objective
High-grade serous ovarian cancer (HGSOC) is a deadly malignancy. Homeobox protein A9 (HOXA9) is linked with serous papillary histotype differentiation, and inappropriate HOXA9 expression is a step in ovarian cancer that induces aberrant differentiation. This study aimed to reveal the significance of HOXA9 in HGSOC.
Methods
HOXA9...

Alternative Titles

Full title

High HOXA9 gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9659939

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9659939

Other Identifiers

ISSN

0300-0605

E-ISSN

1473-2300

DOI

10.1177/03000605221135864

How to access this item